Real World Prostate Cancer Registry

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
Cincinnati Cancer Advisors
Study ID
NCT06355336
Status
Recruiting

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Prostate cancer is the most common cancer diagnosed in men in the USA with 268,490 cases diagnosed in 2022 constituting 27% of male cancers and 34,500 deaths (11%) occurred in same year.1 Prostate cancer is a very heterogeneous disease that has different presentations, molecular and pathological features, stages, and disease biology. The treatment options are dependent on the disease stage, its features, and the patient's condition and preferences. The disease outcome also varies significantly due to the previous heterogeneity of the features in addition to other social determinants of health. Therefore, it is critical to obtain real-world data that reflects the actual patterns of prostate cancer presentation, work up, management, and outcome. Real World Prostate Cancer Registry (RWPCR) aims at compiling real world data from patients presented with prostate cancer in the tristate area. The data collection will be prospective and longitudinal including patients' demographics and disease characteristics, work up, management, and outcome.

Key Dates

Start date
Mar 18, 2024
Status verified
May 2025
Primary completion
Mar 18, 2034
Completion
Mar 18, 2034

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

To determine practice patterns for prostate cancer in the region. [ Time Frame: 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cincinnati Cancer AdvisorsCincinnatiOhio45212
Dr. Jazieh
5137312273
Amy Barber
5137312273
Abdul R Jazieh, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Cincinnati, OH

By condition

Related Studies